Issue #102

May 2020

Lifeblood joins the
COVID-19 fight

Welcome to the May issue of Pathway, a monthly magazine designed for anyone interested in their health and wellbeing and in the integral role that pathology plays in the diagnosis, treatment and management of diseases.

This month’s issue of Pathway looks at the following:

Potentially life-saving genetic testing for range of cancers introduced to MBS

We discuss new MBS items, including genetic testing to identify heritable mutations which increase risk in colorectal and endometrial cancer, and molecular testing for rare and less common (RLC) cancers.

FIND OUT MORE >>

Lifeblood joins fight to combat COVID-19 in Australian first

Lifeblood announced that it is now collecting convalescent plasma for the very first time. Lifeblood Medical Director, Dr James Daly explains how this might help people with active COVID-19 infection.

FIND OUT MORE >>

Blood donation: an essential service

In March 2020, Australian Red Cross Lifeblood reported a significant drop in blood donations, prompting it to take immediate action.

FIND OUT MORE >>

New MBS listing set to identify more individuals and ultimately save lives

This month, genetic testing for heritable mutations associated with Familial Hypercholesterolemia (FH) was added to the MBS. Prof David Sullivan explains what this means for patients.

FIND OUT MORE >>

Controlling COVID-19 in Singapore

Early in January, laboratories in Singapore began implementing pan-coronavirus testing after it was recognised that unexplained pneumonia from Wuhan had similarities to the SARS experience of 2003.

FIND OUT MORE >>

Find out more on the RCPA website

www.rcpa.edu.au

The Royal College of Pathologists of Australasia
Durham Hall - 207 Albion St Surry Hills NSW 2010 AUSTRALIA
Phone: +61 2 8356 5858